Deadline: 5 March 2019
Mott MacDonald, the Fleming Fund Management Agent for Country Grants, is seeking proposals from qualified licensed/registered entities in Senegal to work toward strengthening antimicrobial resistance (AMR) surveillance and response in Senegal.
Work will be carried out in collaboration with the Senegalese High Council for Global Health Security [Haut Conseil de la Sécurité Sanitaire Mondial].
This first Fleming Fund Country Grant for Senegal will focus on putting in place the foundations for antimicrobial resistance (AMR) and antimicrobial use (AMU) surveillance in the human and animal health sectors, as well as some aspects of AMR surveillance in the environment. It will facilitate a stronger One Health approach to surveillance, bringing together multi-sectoral stakeholders to share surveillance data and gain a better understanding of AMR and AMU.
Objectives
The objectives of the grant have been developed and agreed in partnership with the Government of Senegal. The objectives are:
- strengthen One Health governance and data sharing
- strengthen the AMR and antimicrobial usage (AMU) surveillance system in human health
- strengthen the AMR and AMU surveillance system in animal and environmental health
Funding Information
This grant is expected to last 24 months. Grant applications should be in the region of £3-5 million, including all capital and recurrent costs, overheads and management costs.
Eligibility Criteria
Lead grantee applicants must satisfy the following eligibility criteria before applications can be assessed:
- Eligible lead grantee organisations are: National institutes (such as universities or research institutes); Non-Governmental Organisations; UN Agencies; Private companies.
- Can be a single organisation or consortium; if a consortium, lead grantee applicant must evidence it has the appropriate governance, coordination mechanisms, and documented track record to manage sub-grantees.
- Must demonstrate that they are registered to work within the country, including the submission of essential documents such as; current business registration certificate or equivalent, articles of incorporation, current tax clearance certificate, social security certificate, annual audited statements for the past three years.
- Lead grantee applicant must demonstrate they are competent and sufficiently experienced in successfully supporting laboratory capacity development, disease surveillance, capacity building, and One Health in LMICS.
- Lead grantee applicant must demonstrate that they are fully functional in both French and English.
- Lead grantee applicant must be able to provide all information required to demonstrate that adequate and tested financial management controls and levels of authority are in place and are adhered to.
- References from clients for previous work undertaken within the last five years are welcome
How to Apply
- Prospective lead grantees must register their interest to apply via email at the address given on the website to receive an invitation to the Applicant Information Session, and an example of the Application Pack.
- The Applicant Information Session (AIS) will be organised in Dakar, Senegal on 13 March 2019. The details of the venue will be shared with applicants registering their interest.
- Ahead of the AIS, an example Application Pack will be shared and will include the application form, budget and milestones template and Guidance Notes. Following the AIS, the official Application Pack will be sent out to prospective Grantees who have registered their interest to apply for the grant.
For more information, please visit https://www.flemingfund.org/grants/senegal-country-grant/